Literature DB >> 16043714

The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain.

Horea Rus1, Carlos A Pardo, Lina Hu, Erika Darrah, Cornelia Cudrici, Teodora Niculescu, Florin Niculescu, Katharine M Mullen, Rameeza Allie, Liping Guo, Heike Wulff, Christine Beeton, Susan I V Judge, Douglas A Kerr, Hans-Gunther Knaus, K George Chandy, Peter A Calabresi.   

Abstract

Multiple Sclerosis (MS) is characterized by central nervous system perivenular and parenchymal mononuclear cell infiltrates consisting of activated T cells and macrophages. We recently demonstrated that elevated expression of the voltage-gated potassium channel, Kv1.3, is a functional marker of activated effector memory T (T(EM)) cells in experimental allergic encephalomyelitis and in myelin-specific T cells derived from the peripheral blood of patients with MS. Herein, we show that Kv1.3 is highly expressed in postmortem MS brain inflammatory infiltrates. The expression pattern revealed not only Kv1.3(+) T cells in the perivenular infiltrate but also high expression in the parenchyma of demyelinated MS lesions and both normal appearing gray and white matter. These cells were uniformly chemokine receptor 7 negative (CCR7(-)), consistent with an effector memory phenotype. Using double-labeling immunohistochemistry and confocal microscopy, we demonstrated colocalization of Kv1.3 with CD3, CD4, CD8, and some CD68 cells. The expression patterns mirrored in vitro experiments showing polarization of Kv1.3 to the immunological synapse. Kv1.3 was expressed in low to moderate levels on CCR7(+) central memory T cells from cerebrospinal fluid, but, when these cells were stimulated in vitro, they rapidly became Kv1.3(high)/CCR7(-) T(EM), suggesting that a subset of cerebrospinal fluid cells existed in a primed state ready to become T(EM). These studies provide further rationale for the use of specific Kv1.3 antagonists in MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043714      PMCID: PMC1182417          DOI: 10.1073/pnas.0501770102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity.

Authors:  Heike Wulff; Hans-Günther Knaus; Michael Pennington; K George Chandy
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

2.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

Authors:  A E Lovett-Racke; J L Trotter; J Lauber; P J Perrin; C H June; M K Racke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

3.  Potassium Channel Blockers Inhibit Adoptive Transfer of Experimental Allergic Encephalomyelitis by Myelin-Basic-Protein-Stimulated Rat T Lymphocytes.

Authors:  S.I.V. Judge; J.Z. Yeh; M.D. Mannie; L. Pope Seifert; P.Y. Paterson
Journal:  J Biomed Sci       Date:  1997 Jul-Aug       Impact factor: 8.410

4.  Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells.

Authors:  F Sallusto; E Kremmer; B Palermo; A Hoy; P Ponath; S Qin; R Förster; M Lipp; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

5.  Inflammatory cerebrospinal fluid T cells have activation requirements characteristic of CD4+CD45RA- T cells.

Authors:  M Chofflon; V González; H L Weiner; D A Hafler
Journal:  Eur J Immunol       Date:  1989-10       Impact factor: 5.532

Review 6.  Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis.

Authors:  Suhayl Dhib-Jalbut
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

Review 7.  Potassium channels as therapeutic targets for autoimmune disorders.

Authors:  Heike Wulff; Christine Beeton; K George Chandy
Journal:  Curr Opin Drug Discov Devel       Date:  2003-09

8.  Expression of CCR7 in multiple sclerosis: implications for CNS immunity.

Authors:  Pia Kivisäkk; Don J Mahad; Melissa K Callahan; Keith Sikora; Corinna Trebst; Barbara Tucky; Jerome Wujek; Rivka Ravid; Susan M Staugaitis; Hans Lassmann; Richard M Ransohoff
Journal:  Ann Neurol       Date:  2004-05       Impact factor: 10.422

Review 9.  Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

Authors:  V Wee Yong
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

10.  Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells.

Authors:  Laura Rivino; Mara Messi; David Jarrossay; Antonio Lanzavecchia; Federica Sallusto; Jens Geginat
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

View more
  91 in total

1.  Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease.

Authors:  Srikant Rangaraju; Marla Gearing; Lee-Way Jin; Allan Levey
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family.

Authors:  Zong-Yun Chen; You-Tian Hu; Wei-Shan Yang; Ya-Wen He; Jing Feng; Bin Wang; Rui-Ming Zhao; Jiu-Ping Ding; Zhi-Jian Cao; Wen-Xin Li; Ying-Liang Wu
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

3.  A novel role for Kv1.3 blockers: protecting neural progenitor cells from a hostile inflammatory environment.

Authors:  Haiyan Peng; David J Huss
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

Review 4.  Targeting memory T cells in type 1 diabetes.

Authors:  Mario R Ehlers; Mark R Rigby
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

5.  State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine.

Authors:  Malika Faouzi; John Starkus; Reinhold Penner
Journal:  Br J Pharmacol       Date:  2015-10-09       Impact factor: 8.739

6.  Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.

Authors:  Philippe Azam; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Stephen Griffey; Heike Wulff
Journal:  J Invest Dermatol       Date:  2007-02-01       Impact factor: 8.551

7.  The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.

Authors:  Xiaoqin Hua; Tobias Deuse; Yi-Je Chen; Heike Wulff; Mandy Stubbendorff; Ralf Köhler; Hiroto Miura; Florian Länger; Hermann Reichenspurner; Robert C Robbins; Sonja Schrepfer
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

Review 8.  The CNS under pathophysiologic attack--examining the role of K₂p channels.

Authors:  Petra Ehling; Manuela Cerina; Thomas Budde; Sven G Meuth; Stefan Bittner
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

9.  Modulation of Lymphocyte Potassium Channel KV1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin.

Authors:  Seow Theng Ong; Saumya Bajaj; Mark R Tanner; Shih Chieh Chang; Bankala Krishnarjuna; Xuan Rui Ng; Rodrigo A V Morales; Ming Wei Chen; Dahai Luo; Dharmeshkumar Patel; Sabina Yasmin; Jeremy Jun Heng Ng; Zhong Zhuang; Hai M Nguyen; Abbas El Sahili; Julien Lescar; Rahul Patil; Susan A Charman; Edward G Robins; Julian L Goggi; Peng Wen Tan; Pragalath Sadasivam; Boominathan Ramasamy; Siddana V Hartimath; Vikas Dhawan; Janna Bednenko; Paul Colussi; Heike Wulff; Michael W Pennington; Serdar Kuyucak; Raymond S Norton; Christine Beeton; K George Chandy
Journal:  ACS Pharmacol Transl Sci       Date:  2020-05-14

10.  Lack of effect of Z-butylidenephthalide on presynaptic N-type Ca²⁺ channels in isolated guinea-pig ileum.

Authors:  Marcelo Chen; Wun-Chang Ko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.